Neglecting the difference: Does right or left matter in stroke outcome after thrombolysis?

Stroke

Volumn 37, Issue 8, 2006, Pages 2066-2069

  Di Legge, Silvia ^a   Saposnik, Gustavo ^b,d   Nilanont, Yongchai ^c   Hachinski, Vladimir ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MAHIDOL UNIVERSITY   (Thailand)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute stroke; Outcome; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN FUNCTION; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; GROUPS BY AGE; HEMODYNAMICS; HUMAN; HYPERTENSION; LEFT HEMISPHERE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NEUROIMAGING; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RIGHT HEMISPHERE; RISK; SCORING SYSTEM; STATISTICAL ANALYSIS; STROKE; STROKE PATIENT; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NERVOUS SYSTEM; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; TIME;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NERVOUS SYSTEM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33747184541     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000229899.66019.62     Document Type: Article

References (25)

1. Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T; for the Arbeitsgruppe Schlaganfall Hessen. Difference in recognition of right and left hemispheric stroke. Lancet. 2005;366:392-393.
2. Di Legge S, Fang J, Saposnik G, Hachinski V. The impact of lesion side on acute stroke treatment. Neurology. 2005;65:81-86.
3. Fink JN, Selin MH, Kumar S, Silver B, Linfante I, Caplan LR, Schlaugh G. Is the association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemispheric stroke? Stroke. 2002;33:954-958.
4. Lyden P, Claesson L, Havstad S, Ashwood T, Lu M. Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes. Arch Neurol. 2004;61:1677-1680.
5. Ween JE, Alexander MP, D'Esposito M, Roberts M. Factors predictive of stroke outcome in a rehabilitation setting. Neurology. 1996;47:388-392.
6. Aszalos Z, Barsi P, Vitrai J, Nagy Z. Lateralization as a factor in the prognosis of middle cerebral artery territorial infarct. Eur Neurol. 2002;48:141-145.
7. Merino JG, Silver B, Wong E, Foell B, Demaerschalk B, Tamayo A, Poncha F, Hachinski V. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke. 2002;33:141-146.
8. National Institutes of Health. The Framingham Study: an epidemiological investigation of cardiovascular disease. Washington, DC: US Dept of Health, Education, and Welfare; 1971;section 27:1-42.
9. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
10. Saposnik G, Young B, Silver B, Di Legge S, Webster F, Beletsky V, Jain V, Nilanont Y, Hachinski V. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA. 2004;292:1839-1844.
11. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurological improvement after thrombolytic therapy for acute stroke. Neurology. 2005;65:1169-1174.
12. Brown DL, Johnston KC, Wagner DP, Haley EC. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. JAMA. 2004;35:147-150.
13. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1998;19:604-607.
14. Kwiatkowski T, Libman R, Tilley BC, Lewandowski C, Grotta JC, Lyden P, Levine SR, Brott T. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med. 2005;45:377-384.
15. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke. 2001;32:89-93.
16. Felberg RA, Okon NJ, El-Mitwalli A, Burgin WS, Grotta JC, Alexandrov AV. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke. Stroke. 2002;33:1301-1307.
17. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649-1655.
18. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K, Riks-Stroke Collaboration. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34:1970-1975.
19. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36:62-65.
20. Corbetta M, Kincade MJ, Lewis C, Snyder AZ, Sapir A. Neural basis and recovery of spatial attention deficits in spatial neglect. Nat Neurosci. 2005;8:1603-1610.
21. Yoon BW, Morillo CA, Cechetto DF, Hachinski V. Cerebral hemispheric lateralization in cardiac autonomic control. Arch Neurol. 1997;54:741-744.
22. Helms AK, Torbey MT, Hossein Almassi G. Determinants of mortality in stroke patients with right brain damage. Curr Atheroscler Rep. 2005;7:289-295.
23. Restrepo L, Jacobs MA, Barker PB, Beauchamp NJ, Skolasky RL, Keswani SC, Wityk RJ. Etiology of perfusion-diffusion magnetic resonance imaging mismatch patterns. J Neuroimaging. 2005;15:254-260.
24. Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, Huertas R, Delgado P, Purroy F, Molina CA. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005;36:1452-1456.
25. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, Schroth G, Mattle HP. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke. 2005;36:2121-2125.